Active Filters
- Press ReleaseClear filter

May 16, 2023
Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network

Apr 17, 2023
SWOG researchers report results in rare gynecologic cancers from S1609 DART immunotherapy trial

Apr 16, 2023
SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma

Apr 12, 2023
SWOG S2302 Pragmatica-Lung study opens to enrollment, a model for easier, more representative clinical trials

Jan 30, 2023
S1416 trial results show PARP inhibitor benefit in "BRCA-like" triple-negative breast cancer

Jan 20, 2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

Dec 19, 2022
Four decades of NCI-funded NCTN trials gave U.S. patients 14.2 million life-years for a federal investment of $326 per life-year gained

Nov 23, 2022
Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

Nov 21, 2022
SWOG researchers will present 10 abstracts at SABCS 2022. Here are highlights.